AVITA Medical, Inc. (RCEL) Asset Writedowns and Impairment (2019 - 2021)

AVITA Medical (RCEL) has reported Asset Writedowns and Impairment for 3 consecutive years, with $19000.0 the latest figure, recorded in Q3 2021.

• For the quarter ending Q3 2021, Asset Writedowns and Impairment rose 124.68% year-over-year to $19000.0; the trailing twelve-month figure through Dec 2023 stood at $14000.0 (changed N/A YoY), and the FY2023 full-year result was $4000.0, changed N/A from the prior year.
• Asset Writedowns and Impairment rose to $19000.0 in Q3 2021 per RCEL's latest filing, from -$5000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $19000.0 in Q3 2021 and bottomed at -$77000.0 in Q3 2020.
• Historically, Asset Writedowns and Impairment has averaged -$8800.0 across 3 years, with a median of $8000.0 in 2019.
• The sharpest annual moves came in 2020 and 2021: Asset Writedowns and Impairment slumped 1062.5% in 2020, then surged 124.68% in 2021.
• Over 3 years, Asset Writedowns and Impairment stood at $11000.0 in 2019, then slumped by 145.45% to -$5000.0 in 2020, then soared by 480.0% to $19000.0 in 2021.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $19000.0, -$5000.0, and -$77000.0 for Q3 2021, Q4 2020, and Q3 2020 respectively.